127 related articles for article (PubMed ID: 27723613)
21. [Characteristics of extracranial malignant germ cell tumours in two age groups of children (0-10 and 10-18 years). Multicentre experiences].
Drozyńska E; Połczyńska K; Popadiuk S; Niedzwiecki M; Wiśniewski J; Balcerska A; Izycka-Swieszewska E; Bilska K; Balwierz W; Chełmecka L; Chybicka A; Dudeńko I; Karolczyk G; Kowalczyk J; Krawczuk-Rybak M; Kurylak A; Leszczyńska E; Matysiak M; Młynarski W; Pobudejska A; Sobol G; Sońta-Jakimczyk D; Szajdak K; Tredowska-Skoczeń D; Szmyd K; Trelińska J; Urasiński T; Wachowiak J; Wieczorek M; Wiśniewska-Slusarz H; Woźniak S; Woźniak W; Wysocki M
Med Wieku Rozwoj; 2011; 15(1):16-24. PubMed ID: 21786508
[TBL] [Abstract][Full Text] [Related]
22. Survival analysis of children with stage II testicular malignant germ cell tumors treated with surgery or surgery combined with adjuvant chemotherapy.
Lu SY; Sun XF; Zhen ZJ; Qin ZK; Liu ZW; Zhu J; Wang J; Sun FF
Chin J Cancer; 2015 Feb; 34(2):86-93. PubMed ID: 25322864
[TBL] [Abstract][Full Text] [Related]
23. Mature and immature teratomas: results of the first paediatric Italian study.
Lo Curto M; D'Angelo P; Cecchetto G; Klersy C; Dall'Igna P; Federico A; Siracusa F; Alaggio R; Bernini G; Conte M; De Laurentis T; Di Cataldo A; Inserra A; Santoro N; Tamaro P; Indolfi P
Pediatr Surg Int; 2007 Apr; 23(4):315-22. PubMed ID: 17333214
[TBL] [Abstract][Full Text] [Related]
24. Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 study.
Fresneau B; Orbach D; Faure-Conter C; Sudour-Bonnange H; Vérité C; Gandemer V; Pasquet M; Fasola S; Rome A; Raimbault S; Martelli H; Frappaz D; Le Teuff G; Patte C
Eur J Cancer; 2018 May; 95():11-19. PubMed ID: 29604495
[TBL] [Abstract][Full Text] [Related]
25. [Clinical evaluation of nonseminomatous testicular germ cell tumors].
Nukui M; Nakao M; Nakagawa S; Takada H; Ebisui K; Sugimoto K; Watanabe H; Maekawa M
Hinyokika Kiyo; 1991 Oct; 37(10):1281-5. PubMed ID: 1721771
[TBL] [Abstract][Full Text] [Related]
26. Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor.
Kojima T; Kawai K; Tsuchiya K; Abe T; Shinohara N; Tanaka T; Masumori N; Yamada S; Arai Y; Narita S; Tsuchiya N; Habuchi T; Nishiyama H
Int J Urol; 2015 Oct; 22(10):923-7. PubMed ID: 26094715
[TBL] [Abstract][Full Text] [Related]
27. Influence of tumor site and histology on long-term survival in 193 children with extracranial germ cell tumors.
De Backer A; Madern GC; Pieters R; Haentjens P; Hakvoort-Cammel FG; Oosterhuis JW; Hazebroek FW
Eur J Pediatr Surg; 2008 Feb; 18(1):1-6. PubMed ID: 18302061
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors of germ cell and sex cord-stromal ovarian tumors in pediatric age: 5 years experience.
Elashry R; Hemida R; Goda H; Abdel-Hady el-S
J Exp Ther Oncol; 2013; 10(3):181-7. PubMed ID: 24416992
[TBL] [Abstract][Full Text] [Related]
29. High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
Haugnes HS; Laurell A; Stierner U; Bremnes RM; Dahl O; Cavallin-Ståhl E; Cohn-Cedermark G
Acta Oncol; 2012 Feb; 51(2):168-76. PubMed ID: 22175254
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: a prospective evaluation of 71 patients treated in the German cooperative protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89.
Calaminus G; Schneider DT; Bökkerink JP; Gadner H; Harms D; Willers R; Göbel U
J Clin Oncol; 2003 Mar; 21(5):781-6. PubMed ID: 12610174
[TBL] [Abstract][Full Text] [Related]
31. [Testicular malignant tumours. Efficacy of germ cell and sex cord tumours treatment protocol in Poland].
Popadiuk S; Korzon M; Chybicka A; Szmyd K; Dzierzega M; Trelińska J; Kowalczyk JR; Wiśniewska-Slusarz H; Woźniak W; Bilska K; Wachowiak J; Konatkowska B; Wysocki M; Krawczuk-Rybak M; Czauderna P; Szumera M; Sznurkowska K; Renke J
Med Wieku Rozwoj; 2006; 10(3 Pt 1):811-7. PubMed ID: 17317912
[TBL] [Abstract][Full Text] [Related]
32. High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy.
Pinkerton CR; Pritchard J; Spitz L
J Clin Oncol; 1986 Feb; 4(2):194-9. PubMed ID: 2418168
[TBL] [Abstract][Full Text] [Related]
33. Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience.
Cohn-Cedermark G; Stahl O; Tandstad T;
Andrology; 2015 Jan; 3(1):102-10. PubMed ID: 25270123
[TBL] [Abstract][Full Text] [Related]
34. The effect of cisplatin dose and surgical resection in children with malignant germ cell tumors at the sacrococcygeal region: a pediatric intergroup trial (POG 9049/CCG 8882).
Rescorla F; Billmire D; Stolar C; Vinocur C; Colombani P; Cullen J; Giller R; Cushing B; Lauer S; Davis M; Hawkins E; Shuster J; Krailo M
J Pediatr Surg; 2001 Jan; 36(1):12-7. PubMed ID: 11150431
[TBL] [Abstract][Full Text] [Related]
35. [Improved prognosis of intracranial germ cell tumors by intensified therapy: results of the MAKEI 89 therapy protocol].
Göbel U; Bamberg M; Calaminus G; Gnekow AK; Herrmann HD; Lenard HG; Spaar HJ; Niethammer D; Kühl J; Harms D
Klin Padiatr; 1993; 205(4):217-24. PubMed ID: 7690863
[TBL] [Abstract][Full Text] [Related]
36. Testicular germ cell tumors in adolescents - results of the protocol MAHO 98 and the identification of good risk patients.
Göbel U; Calaminus G; Haas R; Teske C; Schönberger S; Schneider DT; Leuschner I; Harms D
Klin Padiatr; 2014 Nov; 226(6-7):316-22. PubMed ID: 25431864
[TBL] [Abstract][Full Text] [Related]
37. Management of Pediatric Malignant Germ Cell Tumors: ICMR Consensus Document.
Agarwala S; Mitra A; Bansal D; Kapoor G; Vora T; Prasad M; Chinnaswamy G; Arora B; Radhakrishnan V; Laskar S; Kaur T; Dhaliwal RS; Rath GK; Bakhshi S
Indian J Pediatr; 2017 Jun; 84(6):465-472. PubMed ID: 28364343
[TBL] [Abstract][Full Text] [Related]
38. Multimodal treatment of malignant sacrococcygeal germ cell tumors: a prospective analysis of 66 patients of the German cooperative protocols MAKEI 83/86 and 89.
Göbel U; Schneider DT; Calaminus G; Jürgens H; Spaar HJ; Sternschulte W; Waag K; Harms D
J Clin Oncol; 2001 Apr; 19(7):1943-50. PubMed ID: 11283126
[TBL] [Abstract][Full Text] [Related]
39. Outcome and late effects of patients treated for childhood vaginal malignant germ cell tumors.
Coppin R; Martelli H; Chargari C; Sudour-Bonnange H; Orbach D; Vérité C; Pasquet M; Saumet L; Piguet C; Patte C; Guérin F; Faure-Conter C; Fresneau B
Pediatr Blood Cancer; 2023 Dec; 70(12):e30697. PubMed ID: 37798818
[TBL] [Abstract][Full Text] [Related]
40. Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group.
Lopes LF; Macedo CR; Aguiar Sdos S; Barreto JH; Martins GE; Sonaglio V; Milone M; Lima ER; Almeida MT; Lopes PM; Watanabe FM; D'Andrea ML; Pianovski MA; Melaragno R; Vianna SM; Moreira ME; Bruniera P; de Oliveira CZ
J Clin Oncol; 2016 Feb; 34(6):603-10. PubMed ID: 26729441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
